Published in Virology on October 01, 2008
Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease. J Virol (2010) 1.61
Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm. Curr Opin HIV AIDS (2009) 1.39
Human regulatory T cells are targets for human immunodeficiency Virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strain. J Virol (2009) 1.27
Gut mucosal FOXP3+ regulatory CD4+ T cells and Nonregulatory CD4+ T cells are differentially affected by simian immunodeficiency virus infection in rhesus macaques. J Virol (2010) 0.99
Immune quiescence: a model of protection against HIV infection. Retrovirology (2013) 0.91
The biology of FoxP3: a key player in immune suppression during infections, autoimmune diseases and cancer. Adv Exp Med Biol (2009) 0.85
The impact of Nucleofection® on the activation state of primary human CD4 T cells. J Immunol Methods (2014) 0.80
Foxp3 inhibits HDAC1 activity to modulate gene expression in human T cells. Virology (2011) 0.79
IL-15 prolongs CD154 expression on human CD4 T cells via STAT5 binding to the CD154 transcriptional promoter. Genes Immun (2014) 0.78
Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza. J Infect Dis (2015) 0.78
T Cell Transcription Factors and Their Impact on HIV Expression. Virology (Auckl) (2013) 0.78
Functional Mechanisms of Treg in the Context of HIV Infection and the Janus Face of Immune Suppression. Front Immunol (2016) 0.76
A Heterozygous RAB27A Mutation Associated with Delayed Cytolytic Granule Polarization and Hemophagocytic Lymphohistiocytosis. J Immunol (2016) 0.76
Expansion and productive HIV-1 infection of Foxp3 positive CD4 T cells at pleural sites of HIV/TB co-infection. J Clin Exp Immunol (2016) 0.75
Control of regulatory T cell development by the transcription factor Foxp3. Science (2003) 40.32
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol (2003) 38.57
Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity (2005) 23.00
An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol (2003) 19.16
FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell (2006) 9.24
Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature (2007) 7.04
Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature (2007) 5.81
Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol (2007) 5.45
IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J Immunol (2007) 5.31
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood (2006) 4.46
HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol (2004) 3.43
Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci U S A (2005) 3.33
Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS (1992) 3.20
The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immunity (1997) 2.66
Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. J Immunol (2006) 2.44
Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals. Proc Natl Acad Sci U S A (2007) 1.82
Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load. Mol Ther (2004) 1.80
NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells. Clin Immunol (2000) 1.74
CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro. AIDS Res Hum Retroviruses (2007) 1.64
Naive precursors of human regulatory T cells require FoxP3 for suppression and are susceptible to HIV infection. J Immunol (2008) 1.44
Structure of NFAT1 bound as a dimer to the HIV-1 LTR kappa B element. Nat Struct Biol (2003) 1.37
Delineation of a novel pathway that regulates CD154 (CD40 ligand) expression. Mol Cell Biol (2003) 1.25
Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis. Ann N Y Acad Sci (2006) 1.25
Large-scale production of CD4+ T cells from HIV-1-infected donors after CD3/CD28 costimulation. J Hematother (1998) 1.16
FoxP3 enhances HIV-1 gene expression by modulating NFkappaB occupancy at the long terminal repeat in human T cells. J Biol Chem (2007) 1.13
Cooperativity between Rad51 and C/EBP family transcription factors modulates basal and Tat-induced activation of the HIV-1 LTR in astrocytes. J Cell Physiol (2006) 0.98
The gammac-cytokine regulated transcription factor, STAT5, increases HIV-1 production in primary CD4 T cells. Virology (2005) 0.95
Nuclear factor of activated T cells is a driving force for preferential productive HIV-1 infection of CD45RO-expressing CD4+ T cells. J Biol Chem (2002) 0.95
T regulatory cells and HIV infection. AIDS Rev (2007) 0.92
NFAT transcription factors control HIV-1 expression through a binding site downstream of TAR region. Immunobiology (2003) 0.90
HIV-1, NFAT, and cyclosporin: immunosuppression for the immunosuppressed? DNA Cell Biol (2001) 0.88
HIV-1 NL4-3, but not IIIB, inhibits JAK3/STAT5 activation in CD4(+) T cells. Virology (2001) 0.87
T-cell activation leads to poor activation of the HIV-1 clade E long terminal repeat and weak association of nuclear factor-kappaB and NFAT with its enhancer region. J Biol Chem (2004) 0.87
Mapping of HIV-1 determinants of apoptosis in infected T cells. Virology (1998) 0.78
Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res (2009) 7.83
2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) (2011) 3.66
An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol (2011) 2.55
Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol (2007) 1.93
Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis Rheum (2011) 1.79
HIV-1 associated dementia: symptoms and causes. Retrovirology (2006) 1.70
Risk factors for temporomandibular joint arthritis in children with juvenile idiopathic arthritis. J Rheumatol (2012) 1.64
Regulation of the murine Nfatc1 gene by NFATc2. J Biol Chem (2002) 1.64
Surface-anchored monomeric agonist pMHCs alone trigger TCR with high sensitivity. PLoS Biol (2008) 1.57
Transcriptional regulation of HIV-1 gene expression by p53. Cell Cycle (2010) 1.47
Pediatric rheumatology for the adult rheumatologist I: therapy and dosing for pediatric rheumatic disorders. J Clin Rheumatol (2005) 1.40
Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients. Rheumatology (Oxford) (2010) 1.38
High prevalence of temporomandibular joint arthritis at disease onset in children with juvenile idiopathic arthritis, as detected by magnetic resonance imaging but not by ultrasound. Arthritis Rheum (2008) 1.31
HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs. J Biol Chem (2011) 1.28
The receptor deformation model of TCR triggering. FASEB J (2007) 1.27
Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). J Rheumatol (2007) 1.26
Delineation of a novel pathway that regulates CD154 (CD40 ligand) expression. Mol Cell Biol (2003) 1.25
Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol (2014) 1.22
Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression. J Biol Chem (2009) 1.21
MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. J Neurosci (2013) 1.21
Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders. J Biol Chem (2011) 1.17
Adenoviral mediated gene transfer of PDGF-B enhances wound healing in type I and type II diabetic wounds. Wound Repair Regen (2004) 1.16
Temporomandibular joint arthritis in juvenile idiopathic arthritis: the forgotten joint. Curr Opin Rheumatol (2006) 1.14
Association of the TRAF1-C5 locus on chromosome 9 with juvenile idiopathic arthritis. Arthritis Rheum (2008) 1.13
Tubulin-mediated binding of human immunodeficiency virus-1 Tat to the cytoskeleton causes proteasomal-dependent degradation of microtubule-associated protein 2 and neuronal damage. J Neurosci (2006) 1.12
Utility of corticosteroid injection for temporomandibular arthritis in children with juvenile idiopathic arthritis. Arthritis Rheum (2005) 1.10
Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus. Arthritis Rheum (2006) 1.09
Glucocorticoid elevation of dexamethasone-induced gene 2 (Dig2/RTP801/REDD1) protein mediates autophagy in lymphocytes. J Biol Chem (2011) 1.08
Effect of HIV-1 Vpr on cell cycle regulators. DNA Cell Biol (2004) 1.08
Cooperative interaction of C/EBP beta and Tat modulates MCP-1 gene transcription in astrocytes. J Neuroimmunol (2005) 1.07
Interplay between HIV-1 Vpr and Sp1 modulates p21(WAF1) gene expression in human astrocytes. J Biol Chem (2004) 1.07
Interleukin 1 receptor antagonist to treat cytophagic histiocytic panniculitis with secondary hemophagocytic lymphohistiocytosis. J Rheumatol (2006) 1.07
Lentiviral gene transfer of SDF-1alpha to wounds improves diabetic wound healing. J Surg Res (2007) 1.06
Complement receptor 3 ligation of dendritic cells suppresses their stimulatory capacity. J Immunol (2007) 1.05
Early growth response-1 protein is induced by JC virus infection and binds and regulates the JC virus promoter. Virology (2008) 1.05
Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil: case report and a review of the pediatric autoimmune pancreatitis literature. Pediatr Rheumatol Online J (2011) 1.04
T cell receptor triggering by force. Trends Immunol (2010) 1.04
An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infection. J Virol (2012) 1.04
Regulation of MCP-1 gene transcription by Smads and HIV-1 Tat in human glial cells. Virology (2003) 1.03
Cdk9 phosphorylates p53 on serine 392 independently of CKII. J Cell Physiol (2006) 1.02
Extensive replicative capacity of human central memory T cells. J Immunol (2004) 1.02
The temporomandibular joint in juvenile idiopathic arthritis: frequently used and frequently arthritic. Pediatr Rheumatol Online J (2009) 1.02
Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis. Arthritis Res Ther (2014) 1.02
Enthesitis in an inception cohort of enthesitis-related arthritis. Arthritis Care Res (Hoboken) (2011) 1.00
Early growth response-1 is required for CD154 transcription. J Immunol (2006) 1.00
Benefit of fluoroscopically guided intraarticular, long-acting corticosteroid injection for subtalar arthritis in juvenile idiopathic arthritis. Pediatr Radiol (2007) 0.98
Cooperativity between Rad51 and C/EBP family transcription factors modulates basal and Tat-induced activation of the HIV-1 LTR in astrocytes. J Cell Physiol (2006) 0.98
MH2 domain of Smad3 reduces HIV-1 Tat-induction of cytokine secretion. J Neuroimmunol (2006) 0.98
Effectiveness and toxicity of methotrexate in juvenile idiopathic arthritis: comparison of 2 initial dosing regimens. J Rheumatol (2010) 0.96
Ligation of CD28 by its natural ligand CD86 in the absence of TCR stimulation induces lipid raft polarization in human CD4 T cells. J Immunol (2005) 0.96
Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr. Biomed Pharmacother (2003) 0.96
Attainment of inactive disease status following initiation of TNF-α inhibitor therapy for juvenile idiopathic arthritis: enthesitis-related arthritis predicts persistent active disease. J Rheumatol (2011) 0.96
p73 Interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28. Mol Cell Biol (2005) 0.96
Benefit of intraarticular corticosteroid injection under fluoroscopic guidance for subtalar arthritis in juvenile idiopathic arthritis. J Rheumatol (2006) 0.96
The gammac-cytokine regulated transcription factor, STAT5, increases HIV-1 production in primary CD4 T cells. Virology (2005) 0.95
Interplay between cdk9 and NF-kappaB factors determines the level of HIV-1 gene transcription in astrocytic cells. Oncogene (2002) 0.95
CT-guided percutaneous steroid injection for management of inflammatory arthropathy of the temporomandibular joint in children. AJR Am J Roentgenol (2007) 0.95
Association of p65 and C/EBPbeta with HIV-1 LTR modulates transcription of the viral promoter. J Cell Biochem (2007) 0.94
Prolonged expression of CD154 on CD4 T cells from pediatric lupus patients correlates with increased CD154 transcription, increased nuclear factor of activated T cell activity, and glomerulonephritis. Arthritis Rheum (2010) 0.94
Human immunodeficiency virus type 1 Tat prevents dephosphorylation of Sp1 by TCF-4 in astrocytes. J Gen Virol (2006) 0.94
Evidence for regulation of long terminal repeat transcription by Wnt transcription factor TCF-4 in human astrocytic cells. J Virol (2002) 0.94
Genetic defects in cytolysis in macrophage activation syndrome. Curr Rheumatol Rep (2014) 0.93
FOXP3 inhibits activation-induced NFAT2 expression in T cells thereby limiting effector cytokine expression. J Immunol (2009) 0.93
HIV-1 Vpr deregulates calcium secretion in neural cells. Brain Res (2009) 0.93
Effective gene suppression using small interfering RNA in hard-to-transfect human T cells. J Immunol Methods (2006) 0.93
HIV-1 Tat increases cell survival in response to cisplatin by stimulating Rad51 gene expression. Oncogene (2004) 0.92
The Vif accessory protein alters the cell cycle of human immunodeficiency virus type 1 infected cells. Virology (2006) 0.92
Human CD8+ T cells do not require the polarization of lipid rafts for activation and proliferation. Proc Natl Acad Sci U S A (2002) 0.92
St. John's Wort protein, p27SJ, regulates the MCP-1 promoter. Mol Immunol (2008) 0.92
Combination therapy of abatacept and anakinra in children with refractory systemic juvenile idiopathic arthritis: a retrospective case series. J Rheumatol (2011) 0.91
Takayasu arteritis presenting as cerebral aneurysms in an 18 month old: A case report. Pediatr Rheumatol Online J (2008) 0.91
Intra-articular corticosteroid injections to the temporomandibular joints are safe and appear to be effective therapy in children with juvenile idiopathic arthritis. J Oral Maxillofac Surg (2012) 0.91
Retinal vasculitis in two pediatric patients with systemic lupus erythematosus: a case report. Pediatr Rheumatol Online J (2013) 0.91
A T cell-specific enhancer of the human CD40 ligand gene. J Biol Chem (2001) 0.90
HIV-1 Vpr: a closer look at the multifunctional protein from the structural perspective. Curr HIV Res (2009) 0.90
High-performance capillary electrophoresis for determining HIV-1 Tat protein in neurons. PLoS One (2011) 0.90
Rituximab therapy for severe refractory chronic Henoch-Schönlein purpura. J Pediatr (2009) 0.90
Host factor transcriptional regulation contributes to preferential expression of HIV type 1 in IL-4-producing CD4 T cells. J Immunol (2012) 0.88
The role of Vpr in the regulation of HIV-1 gene expression. Cell Cycle (2006) 0.88
Identification of a novel protein from glial cells based on its ability to interact with NF-kappaB subunits. J Cell Biochem (2003) 0.88
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Arthritis Rheumatol (2014) 0.87
Acute exposure to ethanol potentiates human immunodeficiency virus type 1 Tat-induced Ca(2+) overload and neuronal death in cultured rat cortical neurons. J Neurovirol (2006) 0.87
Activation of HIV-1 LTR by Rad51 in microglial cells. Cell Cycle (2010) 0.87
Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation. Int Immunol (2003) 0.87
Involvement of the p53 and p73 transcription factors in neuroAIDS. Cell Cycle (2008) 0.87
Treatment of pediatric localized scleroderma with methotrexate. J Rheumatol (2006) 0.87
Puralpha as a cellular co-factor of Rev/RRE-mediated expression of HIV-1 intron-containing mRNA. J Cell Biochem (2008) 0.86
Regulation of the syncytin-1 promoter in human astrocytes by multiple sclerosis-related cytokines. Virology (2007) 0.86
Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome. J Rheumatol (2013) 0.86
Role of p53 in neurodegenerative diseases. Neurodegener Dis (2011) 0.86
C/EBPbeta regulates human immunodeficiency virus 1 gene expression through its association with cdk9. J Gen Virol (2007) 0.86
Negative regulation of AbetaPP gene expression by pur-alpha. J Alzheimers Dis (2008) 0.85
The HIV-1 Vif protein mediates degradation of Vpr and reduces Vpr-induced cell cycle arrest. DNA Cell Biol (2008) 0.85
Septic abscess in a child with juvenile idiopathic arthritis receiving anti-tumor necrosis factor-alpha. J Rheumatol (2006) 0.84